Suppliers / Wuhan Shiji Pharmaceutical

Wuhan Shiji Pharmaceutical

China Updated 9 July 2026

Wuhan Shiji Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and one valid CEP.

1
active US DMFs
1
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Wuhan, China Not on file

What they file, and where

Molecule Regulators Docs
Clozapine EDQM, US FDA 2

Also appears on these molecule pages

Clozapine API

Questions about Wuhan Shiji Pharmaceutical

Does Wuhan Shiji Pharmaceutical hold a US DMF or a CEP?
Wuhan Shiji Pharmaceutical holds 1 active US drug master file and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Wuhan Shiji Pharmaceutical manufacture?
1 registered site is on record, in China (Wuhan). Every site is listed on this page with the register it came from.
What does Wuhan Shiji Pharmaceutical make?
1 molecule is on record against Wuhan Shiji Pharmaceutical, including Clozapine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Wuhan Shiji Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Matrix Pharmacorp shares 1 molecule Cohance Lifesciences shares 1 molecule Cambrex Profarmaco Milano shares 1 molecule Mankind Pharma shares 1 molecule SMS Pharmaceuticals shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability